Summary : An employee wearing a face mask is seen at a workshop of computed tomography (CT) scanners of medical device firm Siemens Healthineers in Shanghai, China, as the country is hit by an outbreak of a new coronavirus, February 24, 2020.
BERLIN, Aug 3 (Reuters) – U.S.-German medical device maker Siemens Healthineers (SHLG.DE) stuck with its outlook for the 2022 financial year on Wednesday as supply-chain headwinds and COVID-19 lock-downs pushed some sales into next quarters.
The company said it expected comparable revenue growth of between 5.5 and 7.5% and adjusted basic earnings per share of between 2.25 euros ($2.29) and 2.35 euros.
During the group’s third quarter, net income fell to 364 million euros from 395 million euros the previous quarter.
An employee wearing a face mask is seen at a workshop of computed tomography (CT) scanners of medical device firm Siemens Healthineers in Shanghai, China, as the country is hit by an outbreak of a new coronavirus, February 24, 2020. REUTERS/Aly SongBERLIN, Aug 3 (Reuters) – U.S.-German medical device maker Siemens Healthineers (SHLG.DE) stuck with its outlook for the 2022 financial year on Wednesday as supply-chain headwinds and COVID-19 lock-downs pushed some sales into next quarters.The company said it expected comparable revenue growth of between 5.5 and 7.5% and adjusted basic earnings per share of between 2.25 euros ($2.29) and 2.35 euros.
